|
Published by: Frost & Sullivan
Published: Aug. 1, 1998
Table of Contents
- Executive Summary
- Introduction to OTC Dermatology Products Market
- Summary of Major Findings
- Research Scope and Methodology
- Research Scope
- Research Methodology
- Strategic Market Overview and Industry Challenges
- Challenges Facing the Pharmaceutical Industry
- OTC Dermatological ProductsMarket: Critical Issues Affecting the Market
- Market Engineering Research for the U.S. OTC Acne Medicated Products Market
- Forecasts of the OTC Acne Medicated Products Market
- Market Engineering Research for the U.S. OTC Anti Fungal Medicated Products Market
- Forecasts of the OTC Topical Anti-Fungal Products Market
- OTC Medicated Vaginal Yeast Infection Products
- Market Engineering Research for the U.S. OTC Anti-Viral Products Market
- Forecasts of the Cold Sores Medicated Products Market
- OTC Keratolytic Products
- Market Engineering Research for the U.S. OTC Medicated Shampoo Products Market
- Forecasts of the OTC Medicated Seborrhea Treatment Medicated Shampoos Market
- OTC Lice Removal Medicated Shampoos Market
- OTC Hair Growth Medicated Shampoos Market
- Market Engineering Research for the U.S. OTC Antipruritic Medicated Products Market
- Forecasts of the OTC Nonsteroidal Antipruritic Medicated Products Market
- OTC Steroidal Antipruritic Medicated Products
- OTC Hemorrhoidal Antipruritic Medicated Products Market
- Market Engineering Research for the U.S. OTC Antiseptic Products Market
- Forecasts of the OTC Antiseptic Products Market
- The Role of Market Engineering in the OTC Dermatology Products Industry
- Integrating Market Engineering into Business Planning
- Using Market Engineering to Address Industry Challenges, Market Trends, and Opportunities
- Implementation of Market Engineering in the Corporate Structure
- Market Engineering Monitoring of the Pharmaceutical Industry
- Database of Key Industry Participants
- Market Participants
- Distributors
- Associations
AbstractIn this report, the OTC dermatological products market is
defined as nonprescription, medicated, FDA-approved products
that are designed and labeled for the treatment of specific
dermatological conditions. Revenues in this market are expected
to reach $2.53 billion in 2003.
Great opportunities exist in this market for both brand
and generic products. Self-treatment in the United States is
increasing in popularity due to the convenience of the self-treatment
alternatives. The rising cost of receiving professional
care also continues to fuel the OTC medicated products market.
The main market competitors include large
pharmaceutical companies, small pharmaceutical companies,
and generic manufacturers. In most markets, competition is
three tiered with few large companies occupying a large market
share. The major competitive challenge for existing companies is
to maintain market share.
Companies compete in a low margin market with
continuing price pressures from competing generic firms.
Marketing and advertisement has to be rationed carefully to
improve product standing without spending too much money on
promotion.
Get Full Details About This Report >>
|
